课题基金 / 基金详情

Analysis of CD26 mediated signal transduction mechanism.

Analysis of CD26 mediated signal transduction mechanism.
CD26介导的信号转导机制分析。
批准号:
09044266
负责人:
MORIMOTO Chikao
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

MORIMOTO Chikao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CD26, a 110 kDa cell surface glycoprotein, exhibits dipeptidyl peptidase IV (DPPIV ; EC3.4.14.5) enzyme activity and plays an important role in T cell costimulation. the function of CD26/dipeptidyl peptidase IV in transendothelial migration was examined using beta-chemokines as chemoattractants. When soluble recombinant CD26 (sCD26/DPPIV^+) was added to the transendothelial chemotaxis system, chemotactic migration of T cells toward RANTES was significantly enhanced. Addition of sCD26 to 50 ng/ml of RANTES enhanced the migratory response by a factor of two compared to RANTES alone, whereas mutant soluble CD26, lacking the DPPIV enzyme activity, had no enhancing effect on RANTES-induced T cell migration. In the process of analyzing the mechanisms of the enhancement of T cell migration by sCD26, we showed that RANTES was cleaved by sCD26 under physiologic conditions at the precise site characteristic of its enzyme specificity. However, synthesized RANTES which lacks two N-terminal amino a … More cids showed a chemotactic activity equivalent to full length RANTES on T cells. Furthermore, addition of sCD26 showed enhancement of T cell migration induced by both forms of RANTES.In contrast to T cells, the truncated RANTES is inactive in chemotaxis of purified monocytes, and supplement of sCD26 but not mCD26 reduced the migratory response of monocytes to RANTES.These results suggest that CD26/DPPIV differentially regulate the chemotactic response of T cells and monocytes to RANTES and furthermore, the finding can partly explain the dominant phenotype at the chronic inflammatory sites in vivo. Stromal cell-derived factor 1alpha (SDF-1alpha) is a chemokine that has been shown to prevent infection of T-tropic HIV strains and is a possible substrate of CD26/DPPIV.We have shown that SDF-1alpha was cleaved at the N-terminal region by CD26/DPPIV and as a result, the inhibitory activity of SDF-1alpha against HIV infection was disappeared. Moreover, the chemotactic activity of SDF-1alpha was also disappeared specifically by DPPIV activity of recombinant soluble CD26. These results suggested that dissemination of T-tropic HIV strains in vivo may be facilitated by CD26/DPPIV via inactivation of functional SDF-1alpha. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
Ohtsuki T: "Negative regulation of the anti‐HIV and chemotactic activity of human stromal cell-derived factor 1α by CD26/DPPIV." FEBS Letter. 431. 236-240 (1998)
Ohtsuki T:“CD26/DPPIV 对人基质细胞衍生因子 1α 的抗 HIV 和趋化活性的负调节。”FEBS Letter。431. 236-240 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hegen M: "Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase." Immunol.90. 257-264 (1997)
Hegen M:“抗体交联 CD26 会诱导酪氨酸磷酸化和丝裂原激活蛋白激酶的激活。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hegen M,Kameoka J,Dong RP,Schlossman SF,and Morimoto C.: "Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase." Immunol.90. 257-264 (1997)
Hegen M、Kameoka J、Dong RP、Schlossman SF 和 Morimoto C.:“抗体交联 CD26 会诱导酪氨酸磷酸化和丝裂原激活蛋白激酶的激活。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Dong R-P,Tachibana K,Hegen M,Soherpe S,Cho D,Schlossman SF,and Morimoto C.: "Correlation of the epitope defined by anti-CD26 mAbs and CD26 function." Mol.Immunol.35. 13-21 (1998)
Dong R-P、Tachibana K、Hegen M、Soherpe S、Cho D、Schlossman SF 和 Morimoto C.:“抗 CD26 mAb 定义的表位与 CD26 功能的相关性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma
    • 批准号:
      24659401
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    To determine the epigenetic regulatory mechanism of cancer stem cells by cell surface molecules.
    • 批准号:
      22650223
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.12万
    • 财政年份:
      2010
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    Basic research of defining the function of CD26 on human immune system and its clinical application for autoimmune diseases.
    Basic Approach for the Development of Molecular Target Therapy for Autoimmune Diseases and Immune-Mediated Disorders.
    • 批准号:
      17109011
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $71.72万
    • 财政年份:
      2005
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    海外基金